skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients

Original Research

(2269) Views  (934) Full article downloads

Authors: Katayoun Derakhshandeh, Marzieh Soheili, Simin Dadashzadeh, et al

Published Date July 2010 Volume 2010:5 Pages 463 - 471
DOI: http://dx.doi.org/10.2147/IJN.S11586

Katayoun Derakhshandeh1, Marzieh Soheili1, Simin Dadashzadeh2, Reza Saghiri3

1Department of Pharmaceutics, Faculty of Pharmacy, University of Medical Science, Kermanshah 67145-1673, Iran; 2Department of Pharmaceutics, Faculty of Pharmacy, Shaheed Beheshti University of Medical Science, Tehran, Iran; 3Deptartment of Biochemistry, Pasteur Institute, Tehran, Iran

Abstract: The purpose in this study was to investigate poly(ethylene glycol)-modified poly (d,l-lactide-co-glycolide) nanoparticles (PLGA-PEG-NPs) loading 9-nitrocamptothecin (9-NC) as a potent anticancer drug. 9-NC is an analog of the natural plant alkaloid camptothecin that has shown high antitumor activity and is currently in the end stage of clinical trial. Unfortunately, at physiological pH, these potent agents undergo a rapid and reversible hydrolysis with the loss of antitumor activity. Previous researchers have shown that the encapsulation of this drug in PLGA nanoparticles could increase its stability and release profile. In this research we investigated PLGA-PEG nanoparticles and their effect on in vitro characteristics of this labile drug. 9-NC-PLGA-PEG nanoparticles with particle size within the range of 148.5 ± 30 nm were prepared by a nanoprecipitation method. The influence of four different independent variables (amount of polymer, percent of emulsifier, internal phase volume, and external phase volume) on nanoparticle drug-loading was studied. Differential scanning calorimetry and X-ray diffractometry were also evaluated for physical characterizing. The results of optimized formulation showed a narrow size distribution, suitable zeta potential (+1.84), and a drug loading of more than 45%. The in vitro drug release from PLGA-PEG NPs showed a sustained release pattern of up to 120 hours and comparing with PLGA-NPs had a significant decrease in initial burst effect. These experimental results indicate that PLGA-PEG-NPs (versus PLGA-NPs) have a better physicochemical characterization and can be developed as a drug carrier in order to treat different malignancies.

Keywords: long circulating nanoparticle, 9-nitrocamptothecin, in vitro characterization




 

Other articles by Dr Katayoun Derakhshandeh



Readers of this article also read:

Adriamycin release from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis
Epigenomics in cancer management
Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation
Amino acid management of Parkinson’s disease: a case study
Elucidation mechanism of different biological responses to multi-walled carbon nanotubes using four cell lines